The National Eye Institute has awarded Wei Li, PhD, a $9.12 million R24 grant to develop a drug to protect infants from eye disorders due to retinopathy of prematurity, according to a press release.
Li, from the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine, invented technology to screen for disease-restricted or selective drug targets. He used this technology to discover a protein called secretogranin III (Scg3), which “selectively exacerbates pathological angiogenesis in ROP but does not regulate physiological angiogenesis in the developing retina of
Uncategorized